NOT FOR DISSEMINATION IN OR INTO THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HERZLIYA, Israel and CALGARY, Alberta, Oct. 20, 2023 /PRNewswire/ — Innocan Pharma Corporation (“Innocan” or the “Company”) (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that…